1. Academic Validation
  2. Natural Dietary Flavonoid Apigenin Mitigates Ulcerative Colitis via Modulating the AMPK/NF-κB/NLRP3 Signaling Axis

Natural Dietary Flavonoid Apigenin Mitigates Ulcerative Colitis via Modulating the AMPK/NF-κB/NLRP3 Signaling Axis

  • J Agric Food Chem. 2025 Dec 22. doi: 10.1021/acs.jafc.5c15405.
Mengsha Zhou 1 2 Xiaoshuang Mao 1 Lin-En Zou 3 Ying Yang 1 Wenli Zhao 1 2 Yinan Yang 1 Shihao Sun 1 2 Zhongyi Mao 4 Peng Li 1 2 Guihong Qi 1
Affiliations

Affiliations

  • 1 Beijing Life Science Academy, Beijing 102299, China.
  • 2 Zhengzhou Tobacco Research Institute of CNTC, Zhengzhou 450001, China.
  • 3 School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • 4 China Tobacco Fujian Industrial Co., Ltd, Xiamen 361000, China.
Abstract

Ulcerative colitis (UC) is a challenging inflammatory disease with higher relapse and lower remission rates, urgently requiring effective and safe complementary treatment options. Apigenin (Api), a natural flavonoid from parsley and celery, exhibits potent antioxidant and anti-inflammatory activities. In mice with 2.5% DSS-induced acute colitis, Api markedly alleviated weight loss, colon shortening, and elevated DAI scores, while restoring mucosal integrity and reducing oxidative stress and inflammation. Mechanistically, Api can directly bind to AMPK to activate it, thereby alleviating oxidative stress and suppressing the NF-κB pathway, which in turn inhibits NLRP3 inflammasome activation. Moreover, Api directly binds to NLRP3, thereby inhibiting inflammasome activation. Through dual targeting of AMPK and NLRP3, Api cooperatively suppresses oxidative stress and inflammation in UC mice. Collectively, these findings demonstrate that Api protects against colitis via modulation of the AMPK/NF-κB/NLRP3 axis, highlighting its potential as a natural anti-inflammatory agent for intestinal health.

Keywords

AMPK/NF-κB/NLRP3 axis; NLRP3 inflammasome; apigenin (Api); ulcerative colitis (UC).

Figures
Products
Inhibitors & Agonists